FBXO32 and myocardial infarction: Metformin upregulates atrogin-1 levels in MI/R myocardium by activating AMPK, enhancing the interactions between atrogin-1 and CHMP2B, preventing CHMP2B accumulation, improving autophagic flux, and reducing myocardial ischemic injury.